 | • レポートコード：B-GIR08C2505 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ゴーシェ病の世界市場について調べ、まとめました。種類別セグメントは、酵素補充療法、基質減少療法等、用途別セグメントは、非神経因性ゴーシェ病、神経因性ゴーシェ病等に区分しました。ゴーシェ病の世界市場概観、企業動向、企業別ゴーシェ病シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ゴーシェ病の市場概観 ・ゴーシェ病の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ゴーシェ病の企業別販売動向、市場シェア、市場集中度、競争動向 ・ゴーシェ病の世界市場規模 ・ゴーシェ病の北米市場分析（アメリカ、カナダ、メキシコ等） ・ゴーシェ病のアメリカ市場規模推移 ・ゴーシェ病のカナダ市場規模推移 ・ゴーシェ病のメキシコ市場規模推移 ・ゴーシェ病のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ゴーシェ病のドイツ市場規模推移 ・ゴーシェ病のイギリス市場規模推移 ・ゴーシェ病のロシア市場規模推移 ・ゴーシェ病のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ゴーシェ病の日本市場規模推移 ・ゴーシェ病の中国市場規模推移 ・ゴーシェ病の韓国市場規模推移 ・ゴーシェ病のインド市場規模推移 ・ゴーシェ病の東南アジア市場規模推移 ・ゴーシェ病の南米市場分析（ブラジル、アルゼンチン等） ・ゴーシェ病の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ゴーシェ病の種類別分析/販売量、売上、市場シェア（酵素補充療法、基質減少療法） ・ゴーシェ病の用途別分析/市場規模（非神経因性ゴーシェ病、神経因性ゴーシェ病） ・ゴーシェ病の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ゴーシェ病の販売チャネル・代理店・貿易業者・ディーラー分析 |
Gaucher disease is an inherited disorder that affects many of the body’s organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.
Scope of the Report:
The technical barriers of Gaucher disease industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Sanofi, Shire, Actelion Pharma, Pfizer, etc.
There are 5 FDA-approved drugs for type I Gaucher’s disease, Cerezyme (imiglucerase) in 1993, Cerdelga (eliglustat) in 2014, VPRIV (velaglucerase alfa) for 2010, Elelyso (taliglucerase alfa) for 2012, and Zavesca (miglustat) in 2003. One KFDA-approved drugs for type I Gaucher’s disease Abcertin® for 2012.
The special provisions for orphan drugs for Gaucher disease is the key driver for the growth of this market. A few companies and researchers are now developing drugs that are in the clinical stage of development. These drugs are expected to aid in the treatment of Gaucher disease and their effectiveness will in turn promote growth in this market in the next few years.
The worldwide market for Gaucher Disease is expected to grow at a CAGR of roughly 2.7% over the next five years, will reach 1906.6 million US$ in 2024, from 1672 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Gaucher Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
Shire
Actelion Pharma
Pfizer (Protalix)
ISU ABXIS
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Enzyme Replacement Therapy
Substrate Reduction Therapy
Market Segment by Applications, can be divided into
Non-neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gaucher Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gaucher Disease, with price, sales, revenue and global market share of Gaucher Disease in 2017 and 2018.
Chapter 3, the Gaucher Disease competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gaucher Disease breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Gaucher Disease market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Gaucher Disease sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gaucher Disease Introduction
1.2 Market Analysis by Type
1.2.1 Enzyme Replacement Therapy
1.2.2 Substrate Reduction Therapy
1.3 Market Analysis by Applications
1.3.1 Non-neuronopathic Gaucher Disease
1.3.2 Neuronopathic Gaucher Disease
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Gaucher Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shire
2.2.1 Business Overview
2.2.2 Gaucher Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Actelion Pharma
2.3.1 Business Overview
2.3.2 Gaucher Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer (Protalix)
2.4.1 Business Overview
2.4.2 Gaucher Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer (Protalix) Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 ISU ABXIS
2.5.1 Business Overview
2.5.2 Gaucher Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ISU ABXIS Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gaucher Disease Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Gaucher Disease Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Gaucher Disease Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Gaucher Disease Manufacturer Market Share in 2018
3.3.2 Top 6 Gaucher Disease Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Gaucher Disease Market Analysis by Regions
4.1 Global Gaucher Disease Sales, Revenue and Market Share by Regions
4.1.1 Global Gaucher Disease Sales and Market Share by Regions (2014-2019)
4.1.2 Global Gaucher Disease Revenue and Market Share by Regions (2014-2019)
4.2 North America Gaucher Disease Sales and Growth Rate (2014-2019)
4.3 Europe Gaucher Disease Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Gaucher Disease Sales and Growth Rate (2014-2019)
4.5 South America Gaucher Disease Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Gaucher Disease Sales and Growth Rate (2014-2019)
5 North America Gaucher Disease by Country
5.1 North America Gaucher Disease Sales, Revenue and Market Share by Country
5.1.1 North America Gaucher Disease Sales and Market Share by Country (2014-2019)
5.1.2 North America Gaucher Disease Revenue and Market Share by Country (2014-2019)
5.2 United States Gaucher Disease Sales and Growth Rate (2014-2019)
5.3 Canada Gaucher Disease Sales and Growth Rate (2014-2019)
5.4 Mexico Gaucher Disease Sales and Growth Rate (2014-2019)
6 Europe Gaucher Disease by Country
6.1 Europe Gaucher Disease Sales, Revenue and Market Share by Country
6.1.1 Europe Gaucher Disease Sales and Market Share by Country (2014-2019)
6.1.2 Europe Gaucher Disease Revenue and Market Share by Country (2014-2019)
6.2 Germany Gaucher Disease Sales and Growth Rate (2014-2019)
6.3 UK Gaucher Disease Sales and Growth Rate (2014-2019)
6.4 France Gaucher Disease Sales and Growth Rate (2014-2019)
6.5 Russia Gaucher Disease Sales and Growth Rate (2014-2019)
6.6 Italy Gaucher Disease Sales and Growth Rate (2014-2019)
7 Asia-Pacific Gaucher Disease by Country
7.1 Asia-Pacific Gaucher Disease Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Gaucher Disease Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Gaucher Disease Revenue and Market Share by Country (2014-2019)
7.2 China Gaucher Disease Sales and Growth Rate (2014-2019)
7.3 Japan Gaucher Disease Sales and Growth Rate (2014-2019)
7.4 Korea Gaucher Disease Sales and Growth Rate (2014-2019)
7.5 India Gaucher Disease Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Gaucher Disease Sales and Growth Rate (2014-2019)
8 South America Gaucher Disease by Country
8.1 South America Gaucher Disease Sales, Revenue and Market Share by Country
8.1.1 South America Gaucher Disease Sales and Market Share by Country (2014-2019)
8.1.2 South America Gaucher Disease Revenue and Market Share by Country (2014-2019)
8.2 Brazil Gaucher Disease Sales and Growth Rate (2014-2019)
8.3 Argentina Gaucher Disease Sales and Growth Rate (2014-2019)
8.4 Colombia Gaucher Disease Sales and Growth Rate (2014-2019)
9 Middle East and Africa Gaucher Disease by Countries
9.1 Middle East and Africa Gaucher Disease Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Gaucher Disease Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Gaucher Disease Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Gaucher Disease Sales and Growth Rate (2014-2019)
9.3 Turkey Gaucher Disease Sales and Growth Rate (2014-2019)
9.4 Egypt Gaucher Disease Sales and Growth Rate (2014-2019)
9.5 Nigeria Gaucher Disease Sales and Growth Rate (2014-2019)
9.6 South Africa Gaucher Disease Sales and Growth Rate (2014-2019)
10 Global Gaucher Disease Market Segment by Type
10.1 Global Gaucher Disease Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Gaucher Disease Sales and Market Share by Type (2014-2019)
10.1.2 Global Gaucher Disease Revenue and Market Share by Type (2014-2019)
10.2 Enzyme Replacement Therapy Sales Growth and Price
10.2.1 Global Enzyme Replacement Therapy Sales Growth (2014-2019)
10.2.2 Global Enzyme Replacement Therapy Price (2014-2019)
10.3 Substrate Reduction Therapy Sales Growth and Price
10.3.1 Global Substrate Reduction Therapy Sales Growth (2014-2019)
10.3.2 Global Substrate Reduction Therapy Price (2014-2019)
11 Global Gaucher Disease Market Segment by Application
11.1 Global Gaucher Disease Sales Market Share by Application (2014-2019)
11.2 Non-neuronopathic Gaucher Disease Sales Growth (2014-2019)
11.3 Neuronopathic Gaucher Disease Sales Growth (2014-2019)
12 Gaucher Disease Market Forecast (2019-2024)
12.1 Global Gaucher Disease Sales, Revenue and Growth Rate (2019-2024)
12.2 Gaucher Disease Market Forecast by Regions (2019-2024)
12.2.1 North America Gaucher Disease Market Forecast (2019-2024)
12.2.2 Europe Gaucher Disease Market Forecast (2019-2024)
12.2.3 Asia-Pacific Gaucher Disease Market Forecast (2019-2024)
12.2.4 South America Gaucher Disease Market Forecast (2019-2024)
12.2.5 Middle East and Africa Gaucher Disease Market Forecast (2019-2024)
12.3 Gaucher Disease Market Forecast by Type (2019-2024)
12.3.1 Global Gaucher Disease Sales Forecast by Type (2019-2024)
12.3.2 Global Gaucher Disease Market Share Forecast by Type (2019-2024)
12.4 Gaucher Disease Market Forecast by Application (2019-2024)
12.4.1 Global Gaucher Disease Sales Forecast by Application (2019-2024)
12.4.2 Global Gaucher Disease Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Gaucher Disease Picture
Table Product Specifications of Gaucher Disease
Figure Global Sales Market Share of Gaucher Disease by Types in 2018
Table Gaucher Disease Types for Major Manufacturers
Figure Enzyme Replacement Therapy Picture
Figure Substrate Reduction Therapy Picture
Figure Gaucher Disease Sales Market Share by Applications in 2018
Figure Non-neuronopathic Gaucher Disease Picture
Figure Neuronopathic Gaucher Disease Picture
Figure United States Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure France Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure UK Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure China Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure India Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Gaucher Disease Revenue (Value) and Growth Rate (2014-2024)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Gaucher Disease Type and Applications
Table Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Gaucher Disease Type and Applications
Table Shire Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Actelion Pharma Basic Information, Manufacturing Base and Competitors
Table Actelion Pharma Gaucher Disease Type and Applications
Table Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer (Protalix) Basic Information, Manufacturing Base and Competitors
Table Pfizer (Protalix) Gaucher Disease Type and Applications
Table Pfizer (Protalix) Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ISU ABXIS Basic Information, Manufacturing Base and Competitors
Table ISU ABXIS Gaucher Disease Type and Applications
Table ISU ABXIS Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gaucher Disease Sales by Manufacturer (2017-2018)
Figure Global Gaucher Disease Sales Market Share by Manufacturer in 2017
Figure Global Gaucher Disease Sales Market Share by Manufacturer in 2018
Table Global Gaucher Disease Revenue by Manufacturer (2017-2018)
Figure Global Gaucher Disease Revenue Market Share by Manufacturer in 2017
Figure Global Gaucher Disease Revenue Market Share by Manufacturer in 2018
Figure Top 3 Gaucher Disease Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Gaucher Disease Manufacturer (Revenue) Market Share in 2018
Figure Global Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Global Gaucher Disease Revenue and Growth Rate (2014-2019)
Table Global Gaucher Disease Sales by Regions (2014-2019)
Table Global Gaucher Disease Sales Market Share by Regions (2014-2019)
Table Global Gaucher Disease Revenue by Regions (2014-2019)
Figure Global Gaucher Disease Revenue Market Share by Regions (2014-2019)
Figure Global Gaucher Disease Revenue Market Share by Regions in 2018
Figure North America Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Europe Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Gaucher Disease Sales and Growth Rate (2014-2019)
Figure South America Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Gaucher Disease Sales and Growth Rate (2014-2019)
Figure North America Gaucher Disease Revenue and Growth Rate (2014-2019)
Table North America Gaucher Disease Sales by Countries (2014-2019)
Table North America Gaucher Disease Sales Market Share by Countries (2014-2019)
Figure North America Gaucher Disease Sales Market Share by Countries (2014-2019)
Figure North America Gaucher Disease Sales Market Share by Countries in 2018
Table North America Gaucher Disease Revenue by Countries (2014-2019)
Table North America Gaucher Disease Revenue Market Share by Countries (2014-2019)
Figure North America Gaucher Disease Revenue Market Share by Countries (2014-2019)
Figure North America Gaucher Disease Revenue Market Share by Countries in 2018
Figure United States Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Canada Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Mexico Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Europe Gaucher Disease Revenue and Growth Rate (2014-2019)
Table Europe Gaucher Disease Sales by Countries (2014-2019)
Table Europe Gaucher Disease Sales Market Share by Countries (2014-2019)
Table Europe Gaucher Disease Revenue by Countries (2014-2019)
Figure Europe Gaucher Disease Revenue Market Share by Countries (2014-2019)
Figure Europe Gaucher Disease Revenue Market Share by Countries in 2018
Figure Germany Gaucher Disease Sales and Growth Rate (2014-2019)
Figure UK Gaucher Disease Sales and Growth Rate (2014-2019)
Figure France Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Russia Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Italy Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Gaucher Disease Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gaucher Disease Sales by Countries (2014-2019)
Table Asia-Pacific Gaucher Disease Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Gaucher Disease Sales Market Share by Countries 2018
Table Asia-Pacific Gaucher Disease Revenue by Countries (2014-2019)
Figure Asia-Pacific Gaucher Disease Revenue Market Share by Countries 2018
Figure China Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Japan Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Korea Gaucher Disease Sales and Growth Rate (2014-2019)
Figure India Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Southeast Asia Gaucher Disease Sales and Growth Rate (2014-2019)
Figure South America Gaucher Disease Revenue and Growth Rate (2014-2019)
Table South America Gaucher Disease Sales by Countries (2014-2019)
Table South America Gaucher Disease Sales Market Share by Countries (2014-2019)
Figure South America Gaucher Disease Sales Market Share by Countries in 2018
Table South America Gaucher Disease Revenue by Countries (2014-2019)
Table South America Gaucher Disease Revenue Market Share by Countries (2014-2019)
Figure South America Gaucher Disease Revenue Market Share by Countries in 2018
Figure Brazil Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Argentina Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Colombia Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Gaucher Disease Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gaucher Disease Sales by Countries (2014-2019)
Table Middle East and Africa Gaucher Disease Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Gaucher Disease Sales Market Share by Countries in 2018
Table Middle East and Africa Gaucher Disease Revenue by Countries (2014-2019)
Table Middle East and Africa Gaucher Disease Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gaucher Disease Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gaucher Disease Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gaucher Disease Sales and Growth Rate (2014-2019)
Figure UAE Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Egypt Gaucher Disease Sales and Growth Rate (2014-2019)
Figure Nigeria Gaucher Disease Sales and Growth Rate (2014-2019)
Figure South Africa Gaucher Disease Sales and Growth Rate (2014-2019)
Table Global Gaucher Disease Sales by Type (2014-2019)
Table Global Gaucher Disease Sales Share by Type (2014-2019)
Table Global Gaucher Disease Revenue by Type (2014-2019)
Table Global Gaucher Disease Revenue Share by Type (2014-2019)
Figure Global Enzyme Replacement Therapy Sales Growth (2014-2019)
Figure Global Enzyme Replacement Therapy Price (2014-2019)
Figure Global Substrate Reduction Therapy Sales Growth (2014-2019)
Figure Global Substrate Reduction Therapy Price (2014-2019)
Table Global Gaucher Disease Sales by Application (2014-2019)
Table Global Gaucher Disease Sales Share by Application (2014-2019)
Figure Global Neuronopathic Gaucher Disease Sales Growth (2014-2019)
Figure Global Gaucher Disease Sales, Revenue and Growth Rate (2019-2024)
Table Global Gaucher Disease Sales Forecast by Regions (2019-2024)
Table Global Gaucher Disease Market Share Forecast by Regions (2019-2024)
Figure North America Sales Gaucher Disease Market Forecast (2019-2024)
Figure Europe Sales Gaucher Disease Market Forecast (2019-2024)
Figure Asia-Pacific Sales Gaucher Disease Market Forecast (2019-2024)
Figure South America Sales Gaucher Disease Market Forecast (2019-2024)
Figure Middle East and Africa Sales Gaucher Disease Market Forecast (2019-2024)
Table Global Gaucher Disease Sales Forecast by Type (2019-2024)
Table Global Gaucher Disease Market Share Forecast by Type (2019-2024)
Table Global Gaucher Disease Sales Forecast by Application (2019-2024)
Table Global Gaucher Disease Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ゴーシェ病市場：世界及び中国市場分析・予測（～2024年） Gaucher Disease Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Gaucher Disease industry with a focus on the Chinese market. The report provides key statistics on the market status of the Gaucher Disease manufacturers and is a…- ゴーシェ病治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Gaucher Disease Treatment market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast…
- ゴーシェ病治療市場：世界及び中国市場分析・予測（～2024年） Gaucher Disease Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Gaucher Disease Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Gaucher Disease Tr…
- ゴーシェ病治療薬市場：世界及び中国市場分析・予測（～2024年） Gaucher Disease Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Gaucher Disease Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Gaucher Disease Drugs manu…
- 酵素補充療法市場：世界及び中国市場分析・予測（～2024年） Enzyme Replacement Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Enzyme Replacement Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Enzyme Replaceme…